Company profile: Avenu Medical
1.1 - Company Overview
Company description
- Provider of the Ellipsys Vascular Access System, a minimally invasive solution for creating arteriovenous fistulas in hemodialysis patients, using thermal energy to fuse tissue without leaving foreign materials, pursuing unmet clinical needs with cost-effective, efficient approaches to vascular access.
Products and services
- Ellipsys Vascular Access System: A minimally invasive, custom-engineered device that creates arteriovenous fistulas for hemodialysis using controlled thermal energy to fuse vessel tissue, leaving no permanent foreign materials
- Minimally Invasive Vascular Access Development: Avenu Medical develops an efficient, industrial-grade approach to hemodialysis access that emphasizes cost-effectiveness and tissue fusion via thermal energy, minimizing foreign materials and procedural trauma
- Hemodialysis Vascular Access Innovation Program: The company architects a custom-engineered methodology addressing unmet needs, enabling AVF creation via thermal tissue fusion with minimal invasiveness and no foreign materials
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Avenu Medical
Valencia Technologies
HQ: United States
Website
- Description: Provider of implantable neuromodulation solutions for urge urinary incontinence, including eCoin, a coin-sized neurostimulator implanted subcutaneously in the lower leg that delivers automatic intermittent tibial nerve stimulation to reduce symptoms, and the eCoin Physician Qualification training program to certify physicians to offer eCoin therapy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Valencia Technologies company profile →
Wright Therapy
HQ: United States
Website
- Description: Provider of home compression therapy solutions and devices for treating lymphedema and chronic venous insufficiency, with a history of innovation including the first sequential gradient pneumatic compression device.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Wright Therapy company profile →
CHF Solutions
HQ: United States
Website
- Description: Provider of innovative cardiac care medical devices, designing and manufacturing a device that removes excess fluid from patients with fluid overload, offering practical solutions to address unmet clinical needs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CHF Solutions company profile →
Thoratec
HQ: United States
Website
- Description: Provider of mechanical circulatory support medical devices for patients with advanced heart failure. A world leader with the broadest product portfolio, including HeartMate LVAS and Thoratec VAD, addressing the full range of clinical needs, with more than 20,000 devices implanted.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Thoratec company profile →
Sadra Medical
HQ: United States
Website
- Description: Provider of minimally invasive alternatives to traditional surgical valve replacement, developing device-based therapies to facilitate and enhance treatment of aortic valve disease and improve patient care.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Sadra Medical company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Avenu Medical
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Avenu Medical
2.2 - Growth funds investing in similar companies to Avenu Medical
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Avenu Medical
4.2 - Public trading comparable groups for Avenu Medical
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →